Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Hypertension Management

Diagnosis and Treatment

  • The American Heart Association and the American College of Cardiology recommend antihypertensive drug therapy for all adults with systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, as well as for adults with systolic blood pressure 130-139 mm Hg or diastolic blood pressure 80-89 mm Hg who have cardiovascular disease or a 10-year atherosclerotic cardiovascular disease risk ≥10% 1, 2
  • Lifestyle modifications are recommended as the cornerstone for prevention and treatment of hypertension, and all adults with systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg should receive antihypertensive medication along with lifestyle modifications 1, 2

Target Blood Pressure

  • The general target for all adults is <130/80 mm Hg, with a target systolic blood pressure <130 mm Hg for adults ≥65 years who are ambulatory and community-living 1, 2
  • For patients with diabetes, chronic kidney disease, or established cardiovascular disease, the target BP is <130/80 mm Hg, as recommended by the European Society of Cardiology 3

Treatment Approach

  • Four primary drug classes are recommended for initial treatment: thiazide or thiazide-like diuretics, ACE inhibitors, angiotensin receptor blockers, and calcium channel blockers 1, 2
  • For most patients with uncomplicated hypertension, start with a combination of two drugs: ACE inhibitor or ARB + CCB or diuretic, and consider single-pill combinations to improve adherence 1
  • For Black patients, initial therapy should include a thiazide-type diuretic or CCB, and consider starting with a 2-drug combination (diuretic + CCB) 1
  • For patients with more severe hypertension, start with 2-drug combination therapy, and if blood pressure remains above target, advance to triple therapy: ACE inhibitor or ARB + CCB + diuretic 1
  • For resistant hypertension, add spironolactone or other diuretic, alpha-blocker, or beta-blocker, and consider referral to a hypertension specialist 1

Lifestyle Modifications

  • A DASH-style eating pattern, emphasizing fruits, vegetables, whole grains, and low-fat dairy products, is recommended for patients with hypertension, as suggested by the American Diabetes Association and the European Society of Cardiology 4, 3
  • Limiting sodium intake to <2,300 mg/day is recommended for patients with hypertension, as suggested by the American Diabetes Association and the European Society of Cardiology 4, 3
  • Engaging in at least 150 minutes of moderate-intensity aerobic activity per week, plus resistance training 2-3 times weekly, is recommended for patients with hypertension, as advised by the American Diabetes Association and the European Society of Cardiology 4, 3
  • Expected systolic blood pressure reductions from lifestyle modifications are:

    Intervention Approximate Systolic BP Reduction
    DASH diet 3-11 mmHg
    Sodium reduction 3-6 mmHg
    Potassium increase 3-5 mmHg
    Physical activity 3-8 mmHg
    Weight management 1 mmHg per kg lost
    Alcohol limitation 3-4 mmHg

Medication Combinations and Special Populations

  • Avoid combining two renin-angiotensin system blockers 1
  • For patients with albuminuria (UACR ≥30 mg/g), initial treatment with an ACE inhibitor or ARB is recommended 4, 10
  • For patients with established coronary artery disease, ACE inhibitors or ARBs are recommended as first-line treatment 4, 10
  • For African American patients, consider starting with a calcium channel blocker + thiazide diuretic combination 11
  • For pregnant patients, avoid ACE inhibitors and ARBs due to teratogenicity, and prefer calcium channel blockers, beta-blockers, or labetalol 12, 13

Monitoring and Follow-up

  • The American Diabetes Association recommends checking serum creatinine and potassium 7-14 days after initiating ACE inhibitors, ARBs, or diuretics, and considering home blood pressure monitoring to assess control between office visits 4
  • The European Society of Cardiology recommends monitoring BP regularly using home or clinic measurements and checking serum creatinine and potassium 7-14 days after initiating ACE inhibitors, ARBs, or diuretics 3, 4
  • Ambulatory or home blood pressure monitoring should be considered to confirm diagnosis when clinic BP shows unusual variability, hypertension is resistant to treatment, symptoms suggest hypotension, or to diagnose "white coat" hypertension 14, 7
  • After initiating therapy, evaluate adherence and therapeutic response monthly until control is achieved, as recommended by the American College of Physicians, and follow up at least yearly once BP is controlled 2, 3

Benefits and Risks of Treatment

  • Treating hypertension can significantly reduce the risk of stroke by 35-40%, heart attacks by 20-25%, and heart failure by 50%, as reported by the American Heart Association 15
  • Target organ damage (TOD) including left ventricular hypertrophy (LVH) and brain volume/white matter changes can occur in young adults with hypertension, with adjusted hazard ratios for cardiovascular events being 1.67, 1.75, and 3.49 for elevated BP, stage 1, and stage 2 hypertension respectively, compared to normal BP 6
  • The 10-year cardiovascular disease (CVD) risk should be assessed, with a threshold of ≥20% indicating the need for more aggressive treatment, as recommended by the British Medical Journal 14

REFERENCES